Drugmakers Oppose Separate Opioid Case for Addicted Children
- Companies say suits should stay before judge in Cleveland
- Babies’ cases are being ‘warehoused’ and lawyers seek a voice
This article is for subscribers only.
Companies making and distributing opioid painkillers opposed a proposal to separate lawsuits filed on behalf of addicted babies from local governments’ cases aimed at recouping costs of battling the public-health crisis spawned by the drugs.
Attorneys for thousands of babies born to opioid addicts asked a panel of federal judges Thursday to carve their cases out of more than 1,400 suits consolidated before an Ohio judge. The suits, filed by U.S. cities and counties, seek billions of dollars in reimbursement for treatment and policing costs. Drugmakers, such as Purdue Pharma LP and Johnson & Johnson, along with distributors such as McKesson Corp. and Cardinal Health Inc., say the move is unnecessary.